1. Determine in-hospital and 28-days mortality rates of critically-ill cirrhotic patients admitted to ICU 2. Evaluate the role of (blood lactate level, lactate/albumin ratio, lactate/bilirubin index and MELD-lactate score) in prediction of mortality compared to other non- lactate containing scores. 3. Study predictors of in-hospital and 28-mortality in these patients.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
To determine the hospital and 28-days mortality rates in critically-ill cirrhotic patients admitted to ICU of Al-Rajhy Universty Hospital.
Timeframe: within 28 days of patients' admission to the Intensive Care Unit.
To evaluate the role of blood lactate level in prediction of 28-days mortality in critically-ill cirrhotic patients.
Timeframe: Blood lactate level will be estimated on the first day of Patients' admission to the ICU.
To evaluate the role of lactate/Albumin ratio in prediction of 28-days mortality in critically-ill cirrhotic patients.
Timeframe: Lactate/Albumin ratio will be calculated on the first day of Patients' admission to the ICU.
To evaluate the role of lactate/bilirubin index in prediction of 28-days mortality in critically-ill cirrhotic patients.
Timeframe: Lactate bilirubin index will be calculated on the first day of Patients' admission to the ICU.
To evaluate the role of MELD-Lactate score in prediction of 28-days mortality in critically-ill cirrhotic patients.
Timeframe: MELD-Lactate score will be calculated on the first day of Patients' admission to the ICU.